6-27400552-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001076781.3(ZNF391):āc.182A>Gā(p.Glu61Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000416 in 1,614,214 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001076781.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000361 AC: 55AN: 152238Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000357 AC: 89AN: 249348Hom.: 0 AF XY: 0.000392 AC XY: 53AN XY: 135304
GnomAD4 exome AF: 0.000421 AC: 616AN: 1461858Hom.: 1 Cov.: 31 AF XY: 0.000459 AC XY: 334AN XY: 727226
GnomAD4 genome AF: 0.000361 AC: 55AN: 152356Hom.: 0 Cov.: 32 AF XY: 0.000362 AC XY: 27AN XY: 74506
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 20, 2021 | The c.182A>G (p.E61G) alteration is located in exon 3 (coding exon 1) of the ZNF391 gene. This alteration results from a A to G substitution at nucleotide position 182, causing the glutamic acid (E) at amino acid position 61 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at